REVOFIL ULTRA

Revofil Ultra – Hyaluronic Acid Filler for Deep Volume and Facial Contouring

Revofil Ultra is a high-density hyaluronic acid dermal filler developed for deep wrinkle correction, structural volume restoration, and advanced facial contouring. Its peptide-enhanced formulation improves skin elasticity while delivering strong lifting capacity and long-lasting results.

Revofil Ultra is part of Rosvia’s professional Hyaluronic Acid Fillers collection, trusted by aesthetic professionals for deep tissue augmentation and non-surgical facial sculpting.

Within the Revofil range, practitioners may also use Revofil Fine for superficial wrinkles and Revofil Plus for moderate wrinkles and volume correction.

Revofil Filler Range

The Revofil dermal filler line provides solutions across all treatment depths:

• Revofil Fine – for fine lines and superficial wrinkles
• Revofil Plus – for moderate wrinkles and contouring
• Revofil Ultra – for deep volume restoration and structural enhancement

This structured approach supports precise product selection based on clinical needs.

Key Ingredients

• Hyaluronic Acid – 23 mg/mL
• Biomimetic Peptides:
      – Oligopeptide-72: helps stabilize hyaluronic acid and prolong results.
      – Oligopeptide-50: supports collagen production and reduces inflammation.

The combination enhances durability, skin regeneration, and overall treatment outcomes.

Clinical Applications

Revofil Ultra is commonly used for:

• Deep nasolabial folds.
• Marionette lines.
• Cheek augmentation.
• Jawline definition.
• Chin projection and facial contouring.

It can also be integrated into advanced treatment plans alongside Collagen Stimulators to support long-term skin regeneration and structural improvement.

Why Professionals Choose Revofil Ultra

• High-density gel for maximum lift and structural support
• Peptide-enhanced formula for improved skin quality
• Long-lasting results with stable HA structure
• Ideal for deep dermis and subcutaneous injections
• Natural-looking contouring and facial definition

Product Specifications

• HA Concentration: 23 mg/mL.
• Volume: 1.0 mL syringe.
• Needles: 2 × 27G (13 mm).
• Injection Depth: Deep dermis to subcutaneous layer.
• Duration: Up to 12 months.
• Manufacturer: Caregen, South Korea.

Safety & Professional Use

Revofil Ultra must be administered by licensed medical professionals trained in dermal filler procedures.

Temporary side effects may include redness, swelling, or bruising.

Patients should avoid alcohol, sun exposure, and strenuous activity for at least 24 hours post-treatment.

Shipping Information

Rosvia ensures fast and secure international delivery, with all products carefully packaged to maintain safety and integrity.

Disclaimer

Products available on Rosvia.com are intended exclusively for licensed medical and aesthetic professionals. Not for personal use or self-administration.